Allerotherapeutics
1 known investors
Allero Therapeutics develops non-invasive immunotherapies for immune-mediated disorders such as autoimmune and allergic diseases and anti-drug antibody (ADA) responses. Its SOMIT (Specific OroMucosal ImmunoTherapy) platform is designed to induce long-lasting antigen-specific immune tolerance.
BiotechHealthtech